A large-scale resource for tissue-specific CRISPR mutagenesis in
CRISPR
D. melanogaster
Resource
conditional mutagenesis
developmental biology
genetic tools
genetics
genomics
large-scale in vivo screens
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
13 02 2020
13 02 2020
Historique:
received:
22
11
2019
accepted:
01
02
2020
pubmed:
14
2
2020
medline:
10
4
2021
entrez:
14
2
2020
Statut:
epublish
Résumé
Genetic screens are powerful tools for the functional annotation of genomes. In the context of multicellular organisms, interrogation of gene function is greatly facilitated by methods that allow spatial and temporal control of gene abrogation. Here, we describe a large-scale transgenic short guide (sg) RNA library for efficient CRISPR-based disruption of specific target genes in a constitutive or conditional manner. The library consists currently of more than 2600 plasmids and 1700 fly lines with a focus on targeting kinases, phosphatases and transcription factors, each expressing two sgRNAs under control of the Gal4/UAS system. We show that conditional CRISPR mutagenesis is robust across many target genes and can be efficiently employed in various somatic tissues, as well as the germline. In order to prevent artefacts commonly associated with excessive amounts of Cas9 protein, we have developed a series of novel UAS-Cas9 transgenes, which allow fine tuning of Cas9 expression to achieve high gene editing activity without detectable toxicity. Functional assays, as well as direct sequencing of genomic sgRNA target sites, indicates that the vast majority of transgenic sgRNA lines mediate efficient gene disruption. Furthermore, we conducted the so far largest fully transgenic CRISPR screen in any metazoan organism, which further supported the high efficiency and accuracy of our library and revealed many so far uncharacterized genes essential for development. Twenty years after the release of the sequence of the human genome, the role of many genes is still unknown. This is partly because some of these genes may only be active in specific types of cells or for short periods of time, which makes them difficult to study. A powerful way to gather information about human genes is to examine their equivalents in ‘model’ animals such as fruit flies. Researchers can use genetic methods to create strains of insects where genes are deactivated; evaluating the impact of these manipulations on the animals helps to understand the roles of the defunct genes. However, the current methods struggle to easily delete target genes, especially only in certain cells, or at precise times. Here, Port et al. genetically engineered flies that carry CRISPR-Cas9, a biological system that can be programmed to ‘cut’ and mutate precise genetic sequences. The insects were also manipulated in such a way that the CRISPR elements could be switched on at will, and their quantity finely tuned. This work resulted in a collection of more than 1,700 fruit fly strains in which specific genes could be deactivated on demand in precise cells. Further experiments confirmed that this CRISPR system could mutate target genes in different parts of the fly, including in the eyes, gut and wings. Port et al. have made their collection of genetically engineered fruit flies publically available, so that other researchers can use the strains in their experiments. The CRISPR technology they refined and developed may also lay the foundation for similar collections in other model organisms.
Autres résumés
Type: plain-language-summary
(eng)
Twenty years after the release of the sequence of the human genome, the role of many genes is still unknown. This is partly because some of these genes may only be active in specific types of cells or for short periods of time, which makes them difficult to study. A powerful way to gather information about human genes is to examine their equivalents in ‘model’ animals such as fruit flies. Researchers can use genetic methods to create strains of insects where genes are deactivated; evaluating the impact of these manipulations on the animals helps to understand the roles of the defunct genes. However, the current methods struggle to easily delete target genes, especially only in certain cells, or at precise times. Here, Port et al. genetically engineered flies that carry CRISPR-Cas9, a biological system that can be programmed to ‘cut’ and mutate precise genetic sequences. The insects were also manipulated in such a way that the CRISPR elements could be switched on at will, and their quantity finely tuned. This work resulted in a collection of more than 1,700 fruit fly strains in which specific genes could be deactivated on demand in precise cells. Further experiments confirmed that this CRISPR system could mutate target genes in different parts of the fly, including in the eyes, gut and wings. Port et al. have made their collection of genetically engineered fruit flies publically available, so that other researchers can use the strains in their experiments. The CRISPR technology they refined and developed may also lay the foundation for similar collections in other model organisms.
Identifiants
pubmed: 32053108
doi: 10.7554/eLife.53865
pii: 53865
pmc: PMC7062466
doi:
pii:
Substances chimiques
RNA
63231-63-0
CRISPR-Associated Protein 9
EC 3.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : SFB/TRR186
Organisme : Deutsche Forschungsgemeinschaft
ID : SFB1324
Organisme : European Research Council
ID : DECODE
Pays : International
Organisme : Deutsche Forschungsgemeinschaft
ID : TRR186
Organisme : European Research Council
ID : Decode
Pays : International
Informations de copyright
© 2020, Port et al.
Déclaration de conflit d'intérêts
FP, CS, MS, BR, FH, JZ, CB, JF, AH, KK, LL, NL, RM, BP, KR, LS, LV, EV, MB No competing interests declared
Références
Methods Mol Biol. 2016;1478:117-143
pubmed: 27730578
Nat Cell Biol. 2008 Feb;10(2):178-85
pubmed: 18193032
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):E2967-76
pubmed: 25002478
Cell. 2006 May 5;125(3):523-33
pubmed: 16678096
Nat Commun. 2019 May 8;10(1):2113
pubmed: 31068592
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12602-7
pubmed: 11675496
Nat Rev Mol Cell Biol. 2014 Sep;15(9):591-600
pubmed: 25145850
IEEE Trans Biomed Eng. 2005 Apr;52(4):652-63
pubmed: 15825867
Science. 2014 Nov 28;346(6213):1258096
pubmed: 25430774
Nature. 2007 Jul 12;448(7150):151-6
pubmed: 17625558
Cell. 2013 Jul 18;154(2):452-64
pubmed: 23870131
Dev Cell. 2013 Jul 15;26(1):101-12
pubmed: 23792147
Genetics. 2009 Aug;182(4):1089-100
pubmed: 19487563
Genetics. 2018 Jun;209(2):381-387
pubmed: 29669732
Nat Methods. 2006 Oct;3(10):777-9
pubmed: 16990807
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11284-9
pubmed: 23798422
Life Sci Alliance. 2019 Jun 13;2(3):
pubmed: 31196871
Nature. 2006 Sep 21;443(7109):359-63
pubmed: 16964239
Nature. 2016 Feb 18;530(7590):344-8
pubmed: 26887495
Annu Rev Biochem. 2016 Jun 2;85:227-64
pubmed: 27145843
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Genet Genomics. 2018 May 20;45(5):273-276
pubmed: 29789221
Sci Rep. 2017 Mar 31;7(1):517
pubmed: 28364122
Elife. 2019 Oct 15;8:
pubmed: 31613218
Genetics. 2018 Mar;208(3):853-874
pubmed: 29487145
G3 (Bethesda). 2018 Nov 6;8(11):3593-3605
pubmed: 30213867
Elife. 2019 Oct 15;8:
pubmed: 31613223
G3 (Bethesda). 2015 May 20;5(7):1493-502
pubmed: 25999583
Genetics. 2015 Jun;200(2):431-41
pubmed: 25855067
Cell. 2006 May 5;125(3):509-22
pubmed: 16678095
Nature. 2016 Sep 22;537(7621):508-514
pubmed: 27626380
Genetics. 2020 Feb 18;:
pubmed: 32071193
Nat Methods. 2011 Apr;8(4):341-6
pubmed: 21378980
Nat Methods. 2016 Oct;13(10):852-4
pubmed: 27595403
Eukaryot Cell. 2014 Nov;13(11):1465-9
pubmed: 25239977
Cell Rep. 2018 Dec 4;25(10):2653-2659.e3
pubmed: 30517854
Genetics. 2017 Jun;206(2):665-689
pubmed: 28592503
Cell Stem Cell. 2015 Dec 3;17(6):663-674
pubmed: 26607382
Neuron. 2006 Nov 9;52(3):425-36
pubmed: 17088209
Genome Biol. 2016 Mar 24;17:55
pubmed: 27013184
Nucleic Acids Res. 2001 Dec 15;29(24):5226-32
pubmed: 11812856
Annu Rev Genet. 2009;43:305-33
pubmed: 19689210
Nature. 2006 Jan 26;439(7075):470-4
pubmed: 16340960
Nature. 2011 Mar 24;471(7339):473-9
pubmed: 21179090
Development. 1993 Jun;118(2):401-15
pubmed: 8223268
Genetics. 2015 Nov;201(3):843-52
pubmed: 26320097
Genetics. 2019 Feb;211(2):459-472
pubmed: 30504366
Genes Dev. 1990 Jul;4(7):1114-27
pubmed: 2120113
Nat Biotechnol. 2015 Apr;33(4):390-394
pubmed: 25690852
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12596-601
pubmed: 11675495
Development. 2017 Oct 15;144(20):3840-3846
pubmed: 28870988
Elife. 2017 Nov 15;6:
pubmed: 29140243
Nat Rev Genet. 2008 Jul;9(7):554-66
pubmed: 18521077
Development. 2013 Jun;140(11):2434-42
pubmed: 23637332
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3570-5
pubmed: 25733849